Home » Uncategorized

Category Archives: Uncategorized

8/14 Colorado Marijuana Workshop for State and Local Public Health- Recording and Materials

https://www.colorado.gov/pacific/cdphe/marijuana-workshop-state-and-local-public-health

Elyse Contreras Retail Marijuana Program & Medical Marijuana Research Grant Program

Programs Coordinator
P 303.692.6455 | F 303.782.0904
4300 Cherry Creek Drive South, Denver, CO 80246
elyse.contreras@state.co.us
We hosted the Marijuana Workshop for State and Local Public Health on Aug. 14, 2014. 
 

Agenda

Presentations:

 

Medical Marijuana Registry – Natalie Riggins

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Natalie%20Riggins%20presentation.pdf

Medical Marijuana Research Grants Program – Ken Gershman

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Ken%20Gershman%20presentation.pdf

Retail Marijuana: Health Effects Surveillance – Tista Ghosh

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Tista%20Ghosh%20presentation.pdf

Retail Marijuana Public Helath Advisory Committee & Occupational Health and Safety Work Group – Mike Van Dyke

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Mike%20VanDyke%20presentationV2.pdf

WIC Surveillance – Jill Bonczynski, Tri-County Health Department

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Jill%20Bonczynski%20Presentation.pdf

Laboratory Contaminant Testing – Laura Gillim-Ross

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Laura%20Gillim-Ross%20presentation.pdf

Perspective of a marijuana insider handouts – Max Montrose

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Max%20Montrose%20Handout.pdf

Perspective of a marijuana insider PowerPoint presentation – Max Montrose

https://www.colorado.gov/pacific/sites/default/files/CHEIS-Max%20Montrose%20presentation.pdf

Perspectives of a recommending physician – Joe Cohen

Office of Behavioral Health Community Prevention Programs and Statewide Efforts – Stan Paprocki, Colorado Department of Human Services

 

Public Health Prevention Services – Ali Maffey, CDPHE and Heath Harmon, Boulder County Public Health

https://www.colorado.gov/pacific/sites/default/files/CHEIS-ALI-MAFFEY-PRESENTATION.pdf

 

***Note from Anna. Please take the time to read this information.

Reschedule DEA Medical Marijuana as Class Five

http://www.justice.gov/dea/druginfo/ds.shtml

 

“The Drug Enforcement Administration was created by President Richard Nixon through an Executive Order in July 1973 in order to establish a single unified command to combat “an all-out global war on the drug menace.” At its outset, DEA had 1,470 Special Agents and a budget of less than $75 million. Today, the DEA has nearly 5,000 Special Agents and a budget of $2.02 billion.”

http://www.justice.gov/dea/about/history.shtml

DEA Drug Schedules

Drugs, substances, and certain chemicals used to make drugs are classified into five (5) distinct categories or schedules depending upon the drug’s acceptable medical use and the drug’s abuse or dependency potential.

The abuse rate is a determinate factor in the scheduling of the drug; for example, Schedule I drugs are considered the most dangerous class of drugs with a high potential for abuse and potentially severe psychological and/or physical dependence.

As the drug schedule changes– Schedule II, Schedule III, etc., so does the abuse potential– Schedule V drugs represents the least potential for abuse. A Listing of drugs and their schedule are located at Controlled Substance Act (CSA) Scheduling or CSA Scheduling by Alphabetical Order.

These lists describes the basic or parent chemical and do not necessarily describe the salts, isomers and salts of isomers, esters, ethers and derivatives which may also be classified as controlled substances. These lists are intended as general references and are not comprehensive listings of all controlled substances.

Please note that a substance need not be listed as a controlled substance to be treated as a Schedule I substance for criminal prosecution. A controlled substance analogue is a substance which is intended for human consumption and is structurally or pharmacologically substantially similar to or is represented as being similar to a Schedule I or Schedule II substance and is not an approved medication in the United States. (See 21 U.S.C. §802(32)(A) for the definition of a controlled substance analogue and 21 U.S.C. §813 for the schedule.)

Schedule I

Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence. Some examples of Schedule I drugs are:

heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote

Schedule II

Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, less abuse potential than Schedule I drugs, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Some examples of Schedule II drugs are:

cocaine, methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone (OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin

Schedule III

Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Some examples of Schedule III drugs are:

Combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), Products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone

Schedule IV

Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are:

Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien

Schedule V

Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes. Some examples of Schedule V drugs are:

cough preparations with less than 200 milligrams of codeine or per 100 milliliters (Robitussin AC), Lomotil, Motofen, Lyrica, Parepectolin

 

***Note from Anna: Reclassify medical marijuana on the DEA class schedule, allow it’s use for home grows, and tax it in reasonable fashion for retail. End the black market. Impeach, recall,or fire any cop or politician on the city, state, and federal levels who doesn’t agree.

Colorado Marijuana Tax Fifth Amendment Hearing on Friday August 22 2014

For immediate release: August 21, 2014

*Please COPY and REDISTRIBUTE*

{Denver} — There will be a preliminary injunction hearing in Denver
District Court on Friday in a lawsuit brought by marijuana civil rights
activists seeking to protect their Fifth Amendment right against
self-incrimination. Plaintiffs will argue in front of The Honorable Judge
John Madden IV that payment of marijuana taxes violates a citizen’s Fifth
Amendment right against self-incrimination, since marijuana remains illegal
under federal law.

*THE PUBLIC IS ENCOURAGED TO ATTEND THIS HEARING*

Date: Friday, August 22, 2014
Time: 9am to 12noon
Location: Denver District Court (Old Building)
1437 Bannock St.
Denver, Colorado
Courtroom #203: The Honorable Judge John Madden IV

Note: Please dress nicely and maintain quiet in the courtroom. Bring a
photo ID with, as you may have to show it to get through courthouse
security.

*BACKGROUND*
Attorney Robert J. Corry, Jr. filed the lawsuit on June 9, 2014 seeking to
permanently end Colorado’s marijuana taxes, on the grounds that payment of
the taxes forces citizens to incriminate themselves as criminals under
federal law.

The complaint was filed on behalf of an unnamed licensed medical and retail
marijuana center, the “No Over Taxation” issue committee (which campaigned
against Proposition AA, the marijuana tax issue approved by Colorado voters
in 2013) and several individuals, including Kathleen Chippi, Larisa
Bolivar, Miguel Lopez and William Chengelis.

Corry is seeking unspecified damages and a refund of all tax monies
collected by the state.

If successful, Corry’s lawsuit could be the basis for overturning ALL
regulations regarding marijuana licensing and registration in Colorado on
the same grounds.

As long as marijuana remains illegal under federal law,
states cannot require people to give any information about themselves in
order to distribute or purchase marijuana. ANY and ALL requirements to
identify oneself would result in a “real and appreciable” risk of
self-incrimination, and would require a citizen to implicate himself in
federal crimes.

As witnesses, the State of Colorado has called attorneys Brian Vicente and
Christian Sederberg, two self-proclaimed “marijuana lawyers” who helped
campaign for Amendment 64, to provide testimony to support the State’s
assertion that payment of these taxes is not incriminating.

Read more about the Fifth Amendment here:
http://en.wikipedia.org/wiki/Fifth_Amendment_to_the_United_States_Constitution

Corry cites a 1973 Colorado Supreme Court case (People vs. Duleff) that
overturned a man’s conviction for “selling marijuana without a license”
because compliance with the licensing requirement would have required that
person to violate his constitutional right against self-incrimination and
reveal a violation of federal law. Corry writes, “The Colorado Supreme
Court held specifically that the Fifth Amendment prohibits state licensing
requirements that force a person to reveal a violation of federal law.”

From the Duleff decision, Corry quotes the Colo. Sup. Ct.:
“The Fifth Amendment prohibits licensing requirements from being used as a
means of discovering past or present criminal activity which is subject to
prosecution by calling attention to the licensee and his
activities….There is no doubt that the information which Duleff would
have been required to disclose would have been useful to the investigation
of his activities, would have substantially increased the risk of
prosecution, and may well have been a direct admission of guilt under
federal law. The Fifth Amendment protects individuals from such compulsory,
incriminating disclosures and provides a complete defense to prosecution.”
– Colorado Supreme Court (1973)

Corry also cites a 1969 US Supreme Court case (Timothy Leary v. United
States) in which the highest court in the country overturned Leary’s
marijuana possession conviction and ruled that the federal Marihuana Tax
Act of 1937 was illegal, due to the fact that a person seeking a tax stamp
and complying with the law would be forced to incriminate himself, in
violation of the Fifth Amendment.

Corry writes, “Marijuana-specific taxes require plaintiffs and any other
person paying said taxes to incriminate themselves as committing multiple
violations of federal law, including but not limited to, participating in,
aiding and abetting, or conspiring to commit a ‘continuing criminal
enterprise’ and ‘money laundering.’ These illegally-collected taxes are
ultimately laundered by the State of Colorado through J.P. Morgan Chase
Bank, which also participates knowingly in the continuing criminal
enterprise.” Item 67, Corry complaint filed 6/9/14.

Corry concludes, “It is illegal for government to retain tax monies
illegally collected in violation of the constitution, so all amounts must
be returned, and all records related to previous tax payments, destroyed.”

Corry asks the Court to:
“Enter a temporary restraining order, preliminary injunction, and/or
permanent injunction ordering the Defendants, and all those acting in
concert with them, to cease and desist from enforcement of the marijuana
tax statutes, to cease and desist from any further collection, deposit, or
laundering of the marijuana taxes, for a full refund of marijuana tax
monies paid by any person or entity, and for destruction of all tax records
and identifying information after full refunds are made.”

“The state can’t have it both ways. If it’s illegal under federal law, you
cannot collect taxes on it,” says Kathleen Chippi, a plaintiff and member
of the Patient and Caregiver Rights Litigation Project. “We have another
case pending in the Colorado Supreme Court now, Coats v. Dish Network,
where Colorado Attorney General John Suthers argues that medical marijuana
patients can be fired from their jobs for using medical marijuana off-duty,
even though it is legal under state law. Suthers argues in the Coats case
that, since marijuana is still illegal under federal law, patients have no
rights.”

“Yet Suthers and Hickenlooper, as kingpins in their continuing criminal
enterprise, happily collect and spend the marijuana taxes, even though they
were collected in spite of multiple clear violations of federal law,”
Chippi concludes.

Read Boulder Weekly article on Federal Preemption issues and the Coats v.
Dish Lawsuit (5/22/14):
http://www.boulderweekly.com/article-12900-local-attorney-argues-fed-laws-donrst-apply-to-mmj.html

*FOR MORE INFORMATION*

Click here to read the complaint
No Over Taxation, et al, v. Hickenlooper, et al
http://www.cannabistherapyinstitute.com/legal/colorado/propaa.complaint.corry.pdf

People v. Duleff (Colorado Supreme Court case)
http://www.cannabistherapyinstitute.com/legal/colorado/people.v.duleff.html

US v. Leary (US Supreme Court case)
http://supreme.justia.com/cases/federal/us/395/6/

Read more about the Fifth Amendment here:
http://en.wikipedia.org/wiki/Fifth_Amendment_to_the_United_States_Constitution

Patient and Caregiver Rights Litigation Project
*DONATE ONLINE*
http://www.cannabislawsuits.com/

Denver 420 Rally
http://420rally.org/

Law Firm of Robert J. Corry, Jr.
http://www.robcorry.com/

*PRESS CONTACTS*

Contact: Robert J. Corry, Jr.: (303) 634-2244
Kathleen Chippi: 888-EAT-HEMP (888-328-4367)

Provided as a Public Service by the:
Cannabis Therapy Institute
Phone: 877-420-4205
Web: http://www.CannabisTherapyInstitute.com/
Email: info@cannabistherapyinstitute.com

 

***Note from Anna: Fight for your right to cannabis or lose it. The politicians have made it very,very clear that all marijuana cultivation is going into the full control of the Federal government, no matter what the state governors think. Dispensaries, activists, and patients had better pay 100 percent attention to this case.  Every state in America is looking at Colorado for direction with setting,or eliminating, cannabis legalization laws.

If the Colorado activists lose, patients in all of the marijuana states can expect mediocre mass-produced GMO’d, barely effective weed for the little people and high-quality organic cannabis for the rich.That is if it isn’t banned altogether due to quality control, supply and demand, or greed issues by the people in control of it’s cultivation.

If citizens refuse to participate in making sure cannabis is legal then definitely learn to grow your own, but don’t be surprised if home grows of any size are met with full police/FBI/DEA response. Rich people will not allow for the poor people to prosper financially with cannabis because it means THEY lose money and the citizens would be united to vote out ALL of the politicians who betrayed them.

Time is running out until the big money fake activists and lobbyists, hell-bent on locking up cannabis for the friends, politicians, and big businesses who pay them, betray the MMJ patients. The lobbyists and politicians will absolutely betray their constituents for Election 2016 profits. Voter abuses have happened before, and they will happen again if the citizens do not very closely monitor the actions of their politicians.

 

AZ Marijuana Cards Likely to Be Accepted at Nevada Dispensaries

http://azmarijuana.com/ By:   |   Posted : Aug.14.14

Nevada Marijuanahttp://azmarijuana.com/arizona-medical-marijuana-news/nevada-dispensaries-accept-arizona-marijuana-cards/

Authorities in Nevada are working on a plan that would allow medical marijuana patients from other states, including Arizona, to purchase medical marijuana at Nevada dispensaries, which will be opening in early 2015.

The bureau chief of the Nevada Division of Public and Behavioral Health said that Nevada’s new medical marijuana program will allow Arizona residents to shop at dispensaries if they are part of the medical marijuana program in Arizona.

Brian Sandoval, the governor of Nevada, has officially said that up to 66 dispensaries will open all over the state, with the first expected to open in Las Vegas at the beginning of 2015.

According to state law, Nevada dispensaries can choose to honor out of state medical marijuana cardholders as long as the state that issued their license has an electronic database of patients that “allows the Division and medical marijuana dispensaries in (Nevada) to access the database.”

This measure would obviously need to first be approved by authorities in Arizona.  Will Humble, director of the Arizona Department of Health Services, is hesitant to believe that this law would ever work out in conjunction with Arizona cardholders because the system in which medical marijuana is sold and regulated is specific to Arizona dispensaries.  However, Nevada authorities are confident that once the organized system is functioning by early 2015, their dispensaries won’t even need to access the database in Arizona, and that onsite dispensary agents will be able to validate the out-of-towners’ licenses.

There are more than a few details that need ironing out, but if all goes according to plan, Arizona medical marijuana cardholders and other states will have a few more reasons to visit Las Vegas next year.

 

Japan to Start Exporting Fukushima Rice to Singapore / “Singapore Was Convinced to Lift Import Restriction”

Rice produced in Fukushima is going to be exported to Singapore.

JA Zen-Noh (The National Federation of Agricultural Cooperative Associations) announced on 8/18/2014.

Since 311, the government of Singapore banned importing Fukushima rice. JA Zen-Noh comments they have convinced the government of Singapore to deregulate the safety level of rice.

Currently the press release is removed from the website of JA Zen-Noh for some reason.

 

http://search.zennoh.or.jp/bizsearch_asp/search?corpId=atc130002&vc=1&layout=1&hits=10&q=%E3%82%B7%E3%83%B3%E3%82%AC%E3%83%9D%E3%83%BC%E3%83%AB%E3%80%80%E8%BC%B8%E5%87%BA&p=1&t%5B%5D=1

 

http://maguro.2ch.sc/test/read.cgi/poverty/1408364601/l50

 

 

You read this now because we’ve been surviving until today.

_____

Français :

Le Japon va commencer à exporter du riz de Fukushima sur Singapour / “Singapour a été convaincu pour lever les restrictions d’importation”

 

Le riz produit à Fukushima va être exporté sur Singapour.

JA Zen-Noh (la Fédération Nationale des Associations de Coopératives Agricoles Japonaises) l’a annoncé ce 18 août 2014.
Le gouvernement de Singapour avait interdit l’importation du riz de Fukushima depuis le 11-3. JA Zen-Noh déclare qu’ils ont convaincu le gouvernement de Singapour de déréguler le niveau de sécurité du riz.

Actuellement, le communiqué de presse a été retiré du site web de la JA Zen-Noh.

http://search.zennoh.or.jp/bizsearch_asp/search?corpId=atc130002&vc=1&layout=1&hits=10&q=%E3%82%B7%E3%83%B3%E3%82%AC%E3%83%9D%E3%83%BC%E3%83%AB%E3%80%80%E8%BC%B8%E5%87%BA&p=1&t%5B%5D=1

http://maguro.2ch.sc/test/read.cgi/poverty/1408364601/l50

Vous pouvez lire ceci parce que nous avons survécu jusqu’à aujourd’hui.

 

***Note from Anna: If that radioactive rice spreads and mixes with Monsanto crops farms worldwide will be contaminated.

Fake Charities, Drug Cartels, Ransom and Extortion: Where Islamist Group Boko Haram Gets Its Cash

Fake Charities, Drug Cartels, Ransom and Extortion: Where Islamist Group Boko Haram Gets Its Cash

http://www.ibtimes.com/fake-charities-drug-cartels-ransom-extortion-where-islamist-group-boko-haram-gets-its-cash-1585743

  • Boko Haram Bomb_Nigeria
    A security barrier marks the scene of a car bomb explosion at St. Theresa Catholic Church (background) at Madalla, Suleja, just outside Nigeria’s capital Abuja on Dec. 25, 2011. Islamist militant group Boko Haram said it planted bombs that exploded on Christmas Day at churches in Nigeria, one of which killed at least 27 people on the outskirts of the capital. Reuters/Afolabi Sotunde
  • Boko Haram attacks
    A woman walks past homes destroyed by the Islamist group Boko Haram in Bama, Borno State on Feb. 20, 2014. Reuters
  • Boko Haram Bomb_Nigeria
    A security barrier marks the scene of a car bomb explosion at St. Theresa Catholic Church (background) at Madalla, Suleja, just outside Nigeria’s capital Abuja on Dec. 25, 2011. Islamist militant group Boko Haram said it planted bombs that exploded on Christmas Day at churches in Nigeria, one of which killed at least 27 people on the outskirts of the capital. Reuters/Afolabi Sotunde
  • Boko Haram attacks
    A woman walks past homes destroyed by the Islamist group Boko Haram in Bama, Borno State on Feb. 20, 2014. Reuters

Just over a year ago, armed men on motorcycles entered a national park in Cameroon, near the Nigerian border, and swiftly abducted a family of vacationing French tourists — a husband and wife and their four children, along with their uncle.

Two months later, the kidnappers released the hostages along with 16 others in exchange for a cool $3.15 million. The transaction was made by French and Cameroonian negotiators, but it was not divulged who made the payments, according to Reuters.

So landed another cash infusion into the coffers of Boko Haram, the West African jihadist militia that has now gained worldwide infamy through the mass kidnapping of school girls in northern Nigeria. Long before its latest wave of attacks, the Islamist group has efficiently financed violent acts in the service of its mission to impose Shariah law through a combination of lucrative criminal enterprises, say experts who track the group. In addition to kidnappings, Boko Haram has secured financing through extortion, cooperation with international drug cartels and operating fake charities, these experts say.

“What is certain about Boko Haram is that the organization is very well funded; without an ever-increasing cash flow, the movement would have died out long ago,” reads a report from the Terrorism Research and Analysis Consortium, a research initiative of the reference publisher Beacham Group.

About a decade ago, shortly after Boko Haram was founded, it drew the majority of its funds from people in surrounding communities who supported its goal of imposing Islamic law while ridding Nigeria of Western influences, according to a report from the National Consortium for the Study of Terrorism and Responses to Terrorism (START) based at the University of Maryland. But that means of fundraising was inherently limited in a country in which 54 percent of people are classified as “extremely poor” by the World Bank.

In more recent times, Boko Haram has broadened its funding by drawing on foreign donors, and other ventures such as fake charity organizations, extortion, and deals with global drug cartels, according to the START report. Its most recent foray — the kidnapping of 276 schoolgirls to sell on the black market as “wives” — is merely the outgrowth of a coherent strategy to find funds for expansion through whatever means necessary.

The term Boko Haram translates to “Western education is forbidden,” in the local Hausa language of the predominantly Muslim region in northern Nigeria where the group is based.

Since its formation in the early 2000s, the militia has been carrying out violent attacks around the country. Since 2009, when the group’s founding leader was killed and replaced by his second-in-command, the attacks have grown significantly more violent and intense, according to the START report. Last year, the U.S. State Department officially designated the group as a “foreign terrorist organization.”

“What Boko Haram achieved in less than a year is quite remarkable,” wrote David Doukhan of the International Institute for Counter-Terrorism, in a 2013 report, citing their reign over many parts of northeastern Nigeria, the institution of Sharia law, tax collection and an Islamic education system to recruit youth to their cause.

This expansion has required increasingly large sources of funding, which has apparently led Boko Haram to ratchet up its methods of raising money.

Boko Haram Targets Despite religious and political overtones, the majority of Boko Haram’s targets have been private citizens.  National Consortium for the Study of Terrorism and Responses to Terrorism (START) / IBTimes

 

“Perhaps less sophisticated than other tactics, kidnapping has become one of the group’s primary funding sources,” wrote Jacob Zenn, African and Eurasian affairs analyst at The Jamestown Foundation, in a recent report.

But the group receives steady support from abroad, including from Al-Qaeda in the Islamic Maghreb, according to the U.S. State Department, while using links to that terrorist group to secure further donations from sympathizers in the United Kingdom and Saudi Arabia, along with weapons and training.

An unnamed United States intelligence official last week told The Daily Beast that the Islamist group had received “strategic direction” from Osama bin Laden.

Boko Haram cloaks its sources of finance through the crafty use of a highly decentralized distribution network, say experts. The group employs an Islamic model of money transfer called “hawala,” based on an honor system and a global network of agents that leaves no trace.

“The very features which make hawala attractive to legitimate customers — efficiency, anonymity and lack of a paper trail — also make the system attractive for the transfer of illicit funds,” reads a report from the U.S. Treasury Department.

Other direct fundraising includes fake charities and nonprofits. Some have reported that the group receives regular payment from local leaders in northern Nigeria to protect their land.

An untraceable flow of money plus loosely guarded borders has created an ideal environment for black market trade. The porosity of Nigeria’s borders offers the group a steady flow of weapons, training, radicalization and funding.

A 2012 report from the Inter-University Center for Terrorism Studies alleges that Nigerian terrorist groups are financed by drug cartels in Latin America.

Lauretta Napoleoni, an Italian journalist and expert on terrorist finance, said this began to happen when the 2001 Patriot Act made it difficult to transfer drugs through the U.S. to Europe.

“Nobody wants to admit that cocaine reaches Europe via West Africa,” said Napoleoni. “This kind of business is a type of business where Islamic terrorist organizations are very much involved.”

Beyond drugs, Boko Haram has joined other criminal groups in Africa in the billion-dollar rhino and elephant poaching industry, according to a recent report from Born Free USA, a wildlife conservation organization.

“While impoverished locals are enlisted to pull the triggers, it is highly organized transnational crime syndicates and militias that run the poaching and reap the lion’s share of the profits, funding terrorism and increasingly war,” wrote New Scientist’s Richard Shiffman.

Using these extensive networks, Boko Haram members can smuggle anything from sugar and flour to weapons or even people across international borders. This, plus kidnapping ransoms and donations from abroad, is one of the most important factors keeping them in business.

Earlier this week, the U.S. State Department announced plans to further its efforts to counter Boko Haram, given the importance of Nigeria as an economic and political leader in Africa.

“The U.S. has a vital interest in helping to strengthen Nigeria’s democratic institutions, boost Nigeria’s prosperity and security, and ensure opportunity for all of its citizens,” according to a public statement.

A major part of their plan includes a counterterrorism finance program, that “aims to restrict Boko Haram’s ability to raise, move and store money.”

CDPHE Meeting on Retail Marijuana Surveillance – Thursday 8/14/2014-Patients and Press *Not* Invited

For immediate release: Aug. 13, 2014

Cannabis Press Association
http://www.cannabispressassociation.com/

Patient and Caregiver Rights Litigation Project
http://www.cannabislawsuits.com/
888-EAT-HEMP

{Denver} — The Colorado Department of Public Health and Environment
(CDPHE) will be holding an all-day meeting on Thursday, Aug. 14, concerning
their expanding roles in “retail marijuana surveillance” and other areas.

*PHYSICAL LOCATION OF MEETING*
Courtyard Marriott Cherry Creek
Skyline Ballroom
1475 South Colorado Blvd.
Denver, CO 80222
Workshop begins at 8:30 am

The CDPHE had previously only regulated medical marijuana. Their new roles in retail marijuana involve at least 6 different departments within the CDPHE. (See page 10 of “Marijuana and CDPHE” presentation below.)

The meeting will be held at the Courtyard Marriott in Denver, but there
will also be a live webinar available (See below for details.)

According to the CDPHE, “no media” will be allowed to attend the meeting,
and the agenda shows that “no patients” have been invited to share their
views in any manner, even though the subject matter directly concerns them.

The Cannabis Press Association (CPA), working with the Patient and
Caregivers Rights Litigation Project (PCRLP), discovered the meeting, after
several patients received an email invitation asking them to register for
the meeting, which was apparently sent accidentally by the CDPHE to the
wrong email distribution list.

In the email, Elyse Contreras, Programs Coordinator for the Retail
Marijuana Program & Medical Marijuana Research Grant Program at the CDPHE,
stated that the purpose of the Aug. 14 meeting is “to update our local
partners on latest information regarding marijuana surveillance, prevention
efforts, medical research, lab regulations, infused product safety and
more!”

Contreras’ invitation stated that “no media” would be allowed to attend.

When the CDPHE discovered they had sent the email invitation to patients in
error, they immediately removed the online registration form from their
website.

The Cannabis Press Association filed a Colorado Open Records Act (CORA)
request last week, asking for the location and webinar login information
for the meeting, as well as a request for the list of invitees to the
meeting.

The CDPHE ignored the CORA requests. However, CPA was able to obtain the
information from reliable sources. (See below.)

*SURVEILLANCE OF PREGNANT WOMEN*
Many topics will be covered at the all-day meeting. A primary focus will be
how the CDPHE will be performing “surveillance” on pregnant women to
determine whether cannabis used during pregnancy is harmful to children.

According to a “Marijuana and Pregnancy” presentation on the CDPHE website,
one of the new CDPHE programs includes “Birth Registry Surveillance”, which
is defined as “surveillance to determine if marijuana could be a factor in
the development of adverse birth outcomes” and includes a “thorough review
of maternal medical records” (See page 9 of “Marijuana and Pregnancy”
presentation below.)

Kathleen Chippi of the Patient and Caregiver Rights Litigation Project sees
this as another attack on patients. “This secret meeting is just another
attack on medical marijuana patients. They want to screen all birth mothers
for cannabis? The CDPHE doesn’t test new moms for GMOs, pesticides,
fracking fluids, caffeine, sugar, or pharmaceutical chemicals, so why focus
on THC, which has been used safely by humans for over 10,000 years?
Cannabis was actually prescribed commonly to ease pregnancy and the
birthing process before it was made illegal in 1937. Natural cannabinoids
(endocannabinoids) are actually abundant in all breast milk and research
has shown that they are essential to a newborn’s development.”

See: Cannabinoids, like those found in marijuana, occur naturally in human
breast milk
http://www.naturalnews.com/036526_cannabinoids_breast_milk_THC.html#ixzz3AKr2v8PH

===================================================================

*MEETING AGENDA*
Click here for agenda for the Aug. 14, 2014 CDPHE/DOR meeting:
http://cannabispressassociation.com/docs/CDPHE.Agenda.for.State.Local.Workshop-8.14.14.pdf

NOTE: The CDPHE claims that this is not a public meeting, but have refused
to provide a list of the official invitees. If you want to attend in
person, it is recommended to arrive early to try to cajole a seat out of
your public officials.

===================================================================
*WEBINAR LOGIN INFORMATION*
From: “Contreras – CDPHE, Elyse” <elyse.contreras@state.co.us>
Date: August 13, 2014 10:51:24 AM MDT
To: undisclosed-recipients:;
Subject: 8/14 Marijuana Webinar Details
Marijuana Workshop for State and Local Public Health

Follow the directions below to join the webinar beginning at 8:30 am
Thursday, August 14th. This is an all day work shop, the agenda is
attached.

This meeting is intended to allow local public health agency
representatives the opportunity to learn more abut marijuana regulation in Colorado.  No public comment or questions will be taken as the meeting is not considered an open meeting as defined in the Colorado Open Meetings Law, Section 24-6-401 et seq. 

Questions on the topics discussed can be
sent to medical.marijuana@state.co.us.

To join the meeting:
https://cdphe.adobeconnect.com/r6e3dlu1pg2/
—————-
If you have never attended an Adobe Connect meeting before:

Test your connection:
https://cdphe.adobeconnect.com/common/help/en/support/meeting_test.htm

Get a quick overview: http://www.adobe.com/products/adobeconnect.html

Elyse Contreras
Programs Coordinator
Retail Marijuana Program & Medical Marijuana Research Grant Program
P 303.692.6455  |  F 303.782.0904
4300 Cherry Creek Drive South, Denver, CO 80246
elyse.contreras@state.co.us
===================================================================

*RELATED CDPHE PRESENTATIONS*
“Marijuana and CDPHE” presentation
http://cannabispressassociation.com/docs/CDPHE.Marijuana.and.CDPHE.Presentation.CORA4.pdf

“Marijuana and Pregnancy” presentation
http://cannabispressassociation.com/docs/CDPHE.Marijuana.Pregnancy.Presentation.pdf

===================================================================
NOTE: This information was obtained as a public service by volunteers
working with the Cannabis Press Association (CPA), working with the Patient
and Caregivers Rights Litigation Project (PCRLP). Please be generous and
make a donation today.

===================================================================

For immediate release: Aug. 13, 2014

Cannabis Press Association
http://www.cannabispressassociation.com/

Patient and Caregiver Rights Litigation Project
http://www.cannabislawsuits.com/
888-EAT-HEMP


Provided as a Public Service by the:
Cannabis Press Association
“Fighting over 77 years of lies and mis-information
with over 10,000 years of history and fact.”
Web: http://www.cannabispressassociation.com/
Email: info@cannabispressassociation.com

***Note from Anna: I wish the DEA officers went after legal (and illegal) methamphetamine,steroid, and Prozac abusers with the same intensity used for illegally profiling legal medical marijuana patients.

Colorado has sold out to big pharmaceutical companies and their petty political lobbyists. It’s disturbing to watch how easy it is for judges and cops to abuse the weakest among them while running like their asses are on fire away from violent offenders on legally-distributed methamphetamines.

Stats on Meth in Colorado:

http://www.justice.gov/archive/ndic/pubs4/4300/meth.htm

National Drug Intelligence Center
Colorado Drug Threat Assessment
May 2003

“…Methamphetamine abuse is increasingly prevalent in Colorado. The number of methamphetamine-related treatment admissions to publicly funded facilities in the state increased from 1,748 in 1997 to 2,037 in 2001, according to data from ADAD. (See Table 1 in Overview section.) Since 1999 treatment admissions for methamphetamine abuse have increased each year, while admissions for cocaine, heroin, and marijuana have declined. According to ADAD, more than 83 percent of patients treated for methamphetamine abuse in 2001 were Caucasian, 54 percent were male, and nearly 33 percent were 35 or older. Nearly 43 percent of methamphetamine abusers treated during 2001 smoked the drug, 32 percent injected it, 19 percent snorted it, and 6 percent used some other method or multiple methods of administration.”

http://www.narconon.org/drug-information/colorado-drug-addiction.html

From Narconon International:

“…Colorado is crossed by eight Interstates: I-15, I-25, I-70, I-76, I-80, I-84, I-90 and I-94. The central location and high ethnic population of Denver and its suburbs makes it a perfect distribution center for drugs coming into the U.S. across the Canadian border, or for drugs being trafficked north from the Southwest border. Fifteen Ports of Entry (POE) from Canada exist in Montana, and Interstates 15 and 90 link these POEs with Denver and Salt Lake City, both major drug distribution points.

…The most dangerous aspect of the drug scene in Colorado and its cities is that drug trafficking and use is on the increase. The biggest threat is the highly addictive and physically damaging ice methamphetamine. Recent supplies of meth have been more pure and lower cost than earlier supplies.”

From Johnny Green at the Weed Blog April 3, 2013:

http://www.theweedblog.com/marijuana-patents-us-patents-on-medical-procedures-involving-cannabinoids/

Spain Study Confirms Hemp Oil Cures Cancer
http://www.endalldisease.com/spain-st…

Federal Government Reports that Marijuana Kills Cancer Cells
http://www.nbcnews.com/id/51148243/ns…

US Patent 4837228
Cannabichromene (CBC)
http://www.google.com/patents/US4837228

US Patent 4189491
Glaucoma Treatment
http://www.google.com/patents/US4189491

US Patent 5631297
Anandamide Compounds
http://www.google.com/patents/US5631297

US Patent 6132762
Pain, inflammation and arthritis
http://www.google.com/patents/US6132762

US Patent 6410588
Cannabidiol and inflammatory diseases
http://www.google.com/patents/US6410588

US Patent 6974568
Treatment for coughs
http://www.google.com/patents/US6974568

US Patent 6630507
Inflammatory and autoimmune diseases
Strokes, Alzheimer’s and Parkinson’s
http://www.google.com/patents/US6630507

US Patent 7741365
Novel polycyclic cannabinoid analogs
http://www.google.com/patents/US7741365

US Patent 7597910
Prostate cancer and prostatitis
http://www.google.com/patents/US7597910

US Patent 7977107
Detecting traces of cannabinoids
http://www.google.com/patents/US7977107

US Patent 8071641
Diabetes and insulitis
http://www.google.com/patents/US8071641

US Patent 8242178
Cannabidiol and autoimmune hepatitis
http://www.google.com/patents/US8242178

US Patent 8034843
Nausea, vomiting and motion sickness
http://www.google.com/patents/US8034843

US Patent Application 20100292345
Cannabigerol (CBG)
http://www.google.com/patents/US20100…

US Patent Application 20080181942
Multiple sclerosis and MS relapse
http://www.google.com/patents/US20080…

US Patent Application 20090197941
Chronic Obstructive Pulmonary Disease
http://www.google.com/patents/US20090…

US Patent Application 20100204312
Treating cell proliferation and cancers
http://www.google.com/patents/US20100…

US Patent Application 20080262099
Inhibition of tumour cell migration
http://www.google.com/patents/US20080…

US Patent Application 20100222437
Gastrointestinal inflammatory and cancers
http://www.google.com/patents/US20100…

Cannabis and Cannabinoid Research Studies…

Scientific Proof Cannabinoids Kill Cancer Cells :

http://youtu.be/mFBBTnv5Xbs

http://redd.it/18qiwn
http://phoenixtears.ca
http://www.phoenixtearsfoundation.com…

Copy and paste links into address bar (one at a time) :

ncbi.nlm.nih.gov/pubmed/19638490
ncbi.nlm.nih.gov/pubmed/22776349
ncbi.nlm.nih.gov/pubmed/16682966
ncbi.nlm.nih.gov/pubmed/12648025
ncbi.nlm.nih.gov/pubmed/19914218
ncbi.nlm.nih.gov/pubmed/15026328
ncbi.nlm.nih.gov/pubmed/16893424
ncbi.nlm.nih.gov/pubmed/15361550
ncbi.nlm.nih.gov/pubmed/19889794
ncbi.nlm.nih.gov/pubmed/19015962
ncbi.nlm.nih.gov/pubmed/19608284
ncbi.nlm.nih.gov/pubmed/17237277
ncbi.nlm.nih.gov/pubmed/11586361
ncbi.nlm.nih.gov/pubmed/14692532
ncbi.nlm.nih.gov/pubmed/16571653
ncbi.nlm.nih.gov/pubmed/18286801
ncbi.nlm.nih.gov/pubmed/16250836
ncbi.nlm.nih.gov/pubmed/17934890
ncbi.nlm.nih.gov/pubmed/12052046
ncbi.nlm.nih.gov/pubmed/19189054
ncbi.nlm.nih.gov/pubmed/18354058
ncbi.nlm.nih.gov/pubmed/19047095
ncbi.nlm.nih.gov/pubmed/10913156
ncbi.nlm.nih.gov/pubmed/9653194
ncbi.nlm.nih.gov/pubmed/18088200
ncbi.nlm.nih.gov/pubmed/16909207
ncbi.nlm.nih.gov/pubmed/17342320
ncbi.nlm.nih.gov/pubmed/19059457
ncbi.nlm.nih.gov/pubmed/12723496
ncbi.nlm.nih.gov/pubmed/19442536
ncbi.nlm.nih.gov/pubmed/16728591
ncbi.nlm.nih.gov/pubmed/19539619
ncbi.nlm.nih.gov/pubmed/16500647
ncbi.nlm.nih.gov/pubmed/19189659
ncbi.nlm.nih.gov/pubmed/14617682
ncbi.nlm.nih.gov/pubmed/18938775
ncbi.nlm.nih.gov/pubmed/11106791
ncbi.nlm.nih.gov/pubmed/19394652
ncbi.nlm.nih.gov/pubmed/20336665
ncbi.nlm.nih.gov/pubmed/19442435
ncbi.nlm.nih.gov/pubmed/15451022
ncbi.nlm.nih.gov/pubmed/18197164
ncbi.nlm.nih.gov/pubmed/16835997
ncbi.nlm.nih.gov/pubmed/11903061
ncbi.nlm.nih.gov/pubmed/17675107
ncbi.nlm.nih.gov/pubmed/17202146
ncbi.nlm.nih.gov/pubmed/19425170
ncbi.nlm.nih.gov/pubmed/18454173
ncbi.nlm.nih.gov/pubmed/17065222
ncbi.nlm.nih.gov/pubmed/10700234
ncbi.nlm.nih.gov/pubmed/16787257
ncbi.nlm.nih.gov/pubmed/15958274
ncbi.nlm.nih.gov/pubmed/16139274
ncbi.nlm.nih.gov/pubmed/16624285
ncbi.nlm.nih.gov/pubmed/16616335
ncbi.nlm.nih.gov/pubmed/11269508
ncbi.nlm.nih.gov/pubmed/19690545
ncbi.nlm.nih.gov/pubmed/12511587
ncbi.nlm.nih.gov/pubmed/20307616
ncbi.nlm.nih.gov/pubmed/16818634
ncbi.nlm.nih.gov/pubmed/17952650
ncbi.nlm.nih.gov/pubmed/16818650
ncbi.nlm.nih.gov/pubmed/16596790
ncbi.nlm.nih.gov/pubmed/15638794
ncbi.nlm.nih.gov/pubmed/15275820
ncbi.nlm.nih.gov/pubmed/12133838
ncbi.nlm.nih.gov/pubmed/18339876
ncbi.nlm.nih.gov/pubmed/9771884
ncbi.nlm.nih.gov/pubmed/10570948
ncbi.nlm.nih.gov/pubmed/12182964
ncbi.nlm.nih.gov/pubmed/19229996

 

‘Chemical Threat': Disaster Looms as Kiev Shells Fall Near Donetsk Plant

http://rt.com/news/179336-chemical-disaster-donetsk-plant/

Rt.com August 11, 2014

Photo from www.stirol.net

Ukraine is at risk of an environmental disaster as Kiev’s army continues to bomb the Donestk region, nearly hitting its largest chemical plant that stores lethal agents, the plant’s spokesperson warned. The minimum impact zone would be at least 300 km.

READ MORE: ‘Spreading the truth’: Spanish volunteers join fight against Kiev in E. Ukraine (VIDEO)

For the past three weeks, the Ukrainian army has been intensely shelling Gorlovka, located in Ukraine’s Donetsk region — home to the nation’s largest chemical plant, Stirol.

“Due to the irresponsible actions of the Ukrainian army, citizens of Ukraine, Russia, and Belarus are exposed to a deadly threat from an ecological disaster on a daily basis, the size of which cannot be predicted,” Pavel Brykov, a spokesman for the plant, said in a YouTube message on Sunday.

A still from YouTube video by SputnikTV allegedly showing remains of a shell at the territory of Gorlovka chemical plant in eastern Ukraine

According to Brykov, an accident at the plant could cause a toxic leak of nitrochlorobenzene – a lethal substance which, if it enters the human body, affects the liver, heart, and bone marrow, causing death.

The minimum impact of the accident would be at least 300 kilometers, Brykov said, adding that the risks of the accident are being silenced in the Ukrainian media.

Stirol is part of the OSTCHEM holding company that belongs to Ukrainian businessman Dmitry Firtash.

Earlier, Firtash claimed there is no risk of a catastrophe since there are no lethal agents stored at the plant. He added that back in May, when the shelling of the region began to intensify, the plant stopped the synthesis and processing of the colorless gas ammonia and evacuated all of its workers.

A still from YouTube video by SputnikTV allegedly shows remains of a shell near the facilities of Gorlovka chemical plant in eastern Ukraine

In their offensive against the eastern Ukrainian militia, Kiev troops have been using multiple-rocket launchers, such as Grad and Uragan – highly indiscriminate weapons designed for destroying enemy forces in the field. If fired at a city, their lack of precision would likely lead to multiple civilian casualties, increasing the risk of a chemical catastrophe.

Just on Thursday, a unique wooden Orthodox church burned to the ground after being hit by an artillery shell in Gorlovka.STIROL chemical plant in the town of Gorlovka in the Donetsk region (Reuters / Valery Belokryl)

The ongoing fighting in eastern Ukraine has already led to more than 1,300 people – both civilians and military troops – being killed in the conflict, and over 4,000 others being wounded. At the same time, around 118,000 people have been internally displaced and 740,000 others have fled to Russia.

The Stirol plant was involved in an accident that killed six people and injured 26 others a year ago, when a colorless gas ammonia was released into the air during repair work. The incident was one of the biggest in the country’s recent history.

Ukraine is also the site of the world’s worst nuclear power plant accident in history. The catastrophic nuclear disaster happened on April 26, 1986 at reactor number four of the Chernobyl nuclear power plant in Ukraine, which was then one of the USSR republics. The plant is located near the city of Pripyat, some 100 km north of the capital Kiev.

As a result of the explosion and fire, a huge radioactive cloud was spread into the atmosphere, covering thousands of miles of Soviet and European territories. Approximately 100,000 square kilometers of land were significantly contaminated.

Thirty-one out of the 237 people diagnosed with acute radiation sickness died within the first three months of the accident. Overall, up to 985,000 people have died as a result of the incident, mainly from cancer due caused by the radiation, according to Global Research.

FDA Eases Restrictions on Experimental Ebola Drug as CDC Warns of ‘Inevitable’ Spread to U.S.

http://rt.com/usa/179100-ebola-fda-drug-cdc-spread/

RT.com August 08, 2014

While Ebola, the deadly disease spreading through parts of West Africa, has no cure, specific treatment or vaccine, there are several experimental drugs being tested in US labs. Now the FDA has lifted its hold on one of those drugs.

The US Food and Drug Administration gave Tekmira Pharmaceuticals verbal confirmation that they modified the full clinical hold the regulatory agency had placed on the company’s experimental TKM-Ebola drug, enabling the potential use on Ebola patients, Tekmira said in a statement.

“We are pleased that the FDA has considered the risk-reward of TKM-Ebola for infected patients. We have been closely watching the Ebola virus outbreak and its consequences, and we are willing to assist with any responsible use of TKM-Ebola. The foresight shown by the FDA removes one potential roadblock to doing so,” said Dr. Mark Murray, CEO and president of Tekmira.

“This current outbreak underscores the critical need for effective therapeutic agents to treat the Ebola virus. We recognize the heightened urgency of this situation, and are carefully evaluating options for use of our investigational drug within accepted clinical and regulatory protocols.”

The company, in collaboration with infectious disease researchers from Boston University and the United States Army Medical Research Institute for Infectious Diseases, showed the drug’s ability to protect non-human primates from Ebola in preclinical trials in May 2010, Tekmira said.

A Phase I clinical trial ‒ the first step towards FDA approval ‒ began on humans in January. The agency then approved a fast-track designation for the drug in March, around the same time the Ebola outbreak began in Guinea, Liberia and Sierra Leone. It has since spread to Nigeria. According to World Health Organization figures published on Wednesday, there are over 1,700 suspected and confirmed cases of Ebola in the four countries, and 932 of those patients have died from the disease.

A different drug, ZMapp by Mapp Biopharmaceutical Inc., was used to treat two American aid workers who had contracted Ebola in Liberia. ZMapp, previously only known as “a secret serum,” has not been given the go-ahead to begin human trials yet, Forbes reported. It works by boosting the immune system to battle against Ebola. The treatment consists of antibodies from lab animals exposed to the virus.

After receiving a dose of the serum, both Nancy Writebol and Dr. Kent Brantly were transferred to Atlanta’s Emory University Hospital, near the US Centers for Disease Control and Prevention. Brantly, 33, who is an employee of the international group Samaritan’s Purse, also received a blood transfusion from a 14-year-old Ebola survivor, who had been under his care before. Both American patients appear to be improving, officials have said.

With the arrival of Ebola in the US via the two aid workers ‒ who remain in isolation in Atlanta ‒ CDC Director Tom Frieden told Congress that the disease will “inevitably” spread around the world due to global air travel, but that any outbreak in the US would not be large.

Frieden testified on the epidemic in front of the House Subcommittee on Africa, Global Health, Global Human Rights and International Organizations on Thursday. “It is certainly possible that we could have ill people in the US who develop Ebola after having been exposed elsewhere,” he said in his testimony. “But we are confident that there will not be a large Ebola outbreak in the US.”

As people who have traveled to West Africa and then return to or continue on to other destinations develop Ebola-like symptoms, such as fever and gastrointestinal distress, other nations have begun testing for the disease. On Tuesday, Great Britain announced a person in Wales was being monitored by health officials following a potential exposure to the virus.

On Monday, the US experienced its first scare. Mount Sinai Hospital in Manhattan performed tests on a male patient with high fever and gastrointestinal symptoms, the hospital said in a statement. He arrived in the emergency room Monday morning, and had previously traveled to one of the West African countries where Ebola has been reported. However, by the end of the day, officials confirmed the patient had not contracted the deadly disease.

“We are all connected and inevitably there will be travelers, American citizens and others who go from these three countries ‒ or from Lagos if it doesn’t get it under control ‒ and are here with symptoms,” Frieden said.

But that does not mean that the US will become the next battlefront against the disease, a CDC spokesman clarified after Frieden’s testimony.

“It is inevitable that people are going to show up with symptoms. It is possible that some of them are going to have Ebola,” CDC spokesman Tom Skinner said, according to AFP.

****Note from Anna: The government has just made the entire nation’s citizens research test subjects for the plague. Ebola spreads faster in people with weakened immune systems. The only substance on the planet that can make the immune system strong enough to fight it is cannabis. Obama knows this. Why hasn’t the President legalized cannabis nationwide?

Authors:

Pharmacol Res. Author manuscript; available in PMC Feb 24, 2011.
Published in final edited form as:
PMCID: PMC3044336
NIHMSID: NIHMS182272

“Cannabinoid pharmacology has made important advances in recent years after the discovery of the cannabinoid receptors. These discoveries have added to our understanding of exogenous and endogenous cannabinoid signaling along with exploring the various pathways of their biosynthesis, molecular structure, inactivation, and anatomical distribution of their receptors throughout the body. The endocannabinoid system is involved in immunoregulation and neuroprotection. In this article, we have reviewed the possible mechanisms of the regulation of the immune response by endocannabinoids which include modulation of immune response in different cell types, effect on cytokine network, induction of apoptosis in immune cells and downregulation of innate and adaptive immune response.

Studies from our laboratory have suggested that administration of endocannabinoids or use of inhibitors of enzymes that breakdown the endocannabinoids, leads to immunosuppression and recovery from immune-mediated injury to organs such as the liver. Thus, manipulation of endocannabinoids in vivo may constitute a novel treatment modality against inflammatory disorders.”

Endocannabinoids and immune regulation

Info about Ebola: Ebola Hemorrhagic Fever

Washington State Department of Health Medical Marijuana Authorization Practice Guidelines Public Hearing August 8, 2014

Repost for , July 31, 2014

From: Washington State Department of Health
Date:07/25/2014 6:09 PM (GMT-06:00)
To: MEDICALCANNABIS@LISTSERV.WA.GOV
Subject: Medical Marijuana Authorization Practice Guidelines

July 25, 2014
Medical Marijuana Authorization Practice Guidelines
The Department of Health is facilitating a workgroup of representatives from the boards and commissions whose health care professionals can authorize the medical use of marijuana.•  Nursing Care Quality Assurance Commission
•  Board of Naturopathy
•  Medical Quality Assurance Commission
•  Board of Osteopathic Medicine and Surgery

The workgroup will develop draft guidelines to describe the professional practice standards for health care professionals who authorize the medical use of marijuana under chapter 69.51A RCW.

Where:

Department of Health
Point Plaza East
Room 152/153
310 Israel Road SE
Tumwater, WA 98501
360-236-4700

When
August 8, 2014
8:30 a.m.

The public is invited to attend. Thirty minutes have been allotted for public testimony. If you are unable to attend this workgroup meeting, please submit written comments by close of business Thursday, August 7, 2014, at medicalmarijuana@doh.wa.gov.

Agreement on the guidelines may require additional effort by the workgroup, in which case future meetings will be scheduled and notice will be sent to interested persons.

Once completed, the draft guidelines will be shared with each board and commission at regularly scheduled business meetings for review and possible adoption.

***Note from Anna: I am only going to say this once more: If Washington State dispensaries, businesses, and patients don’t unite to put these politicians in line they will be micromanaging your medicines, and taxes in relation to them, from now on. You’ll never be free of the political posturing and bullshit.
If you cannot go please send a proxy to speak for you.
 
If you would like me to write a letter on your behalf use this email address: annajaya67@yahoo.com.
If I get any nonsense, SPAM, or negativity you’ll get blocked and/or your info will be turned over to whoever is necessary.
Activists you can email me for my phone number. I am not certain I will be able to attend the meeting in person because I’m in California on the 7th but if I can make it on a late flight I will.